Molecular Partners AG (MOLN.SW)
CHF 4.83
(4.43%)
CHF 4.83
(4.43%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | - CHF | 0.0% |
| 2022 | - CHF | -100.0% |
| 2021 | 2.00 CHF | 100.0% |
| 2020 | -199 Thousand CHF | 59.05% |
| 2019 | -486 Thousand CHF | 78.8% |
| 2018 | -2.29 Million CHF | 75.7% |
| 2017 | -9.43 Million CHF | -943400100.0% |
| 2016 | 1.00 CHF | -100.0% |
| 2015 | 126.47 Thousand CHF | -66.69% |
| 2014 | 379.67 Thousand CHF | 0.0% |
| 2013 | - CHF | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | - CHF | 0.0% |
| 2024 Q3 | - CHF | 0.0% |
| 2024 Q1 | - CHF | 0.0% |
| 2023 Q3 | 1.00 CHF | 0.0% |
| 2023 FY | - CHF | 0.0% |
| 2023 Q1 | 1.00 CHF | 0.0% |
| 2023 Q4 | - CHF | -100.0% |
| 2023 Q2 | - CHF | -100.0% |
| 2022 Q2 | - CHF | -100.0% |
| 2022 Q4 | - CHF | -100.0% |
| 2022 Q1 | 1.00 CHF | 100.0% |
| 2022 Q3 | 1.00 CHF | 0.0% |
| 2022 FY | - CHF | -100.0% |
| 2021 FY | 2.00 CHF | 100.0% |
| 2021 Q2 | 1.00 CHF | 0.0% |
| 2021 Q4 | -2.01 Million CHF | 74.21% |
| 2021 Q3 | -7.81 Million CHF | -781600100.0% |
| 2021 Q1 | 1.00 CHF | 0.0% |
| 2020 Q2 | -1.54 Million CHF | 0.0% |
| 2020 Q4 | - CHF | 0.0% |
| 2020 Q1 | - CHF | 0.0% |
| 2020 FY | -199 Thousand CHF | 59.05% |
| 2019 Q4 | - CHF | 0.0% |
| 2019 FY | -486 Thousand CHF | 78.8% |
| 2019 Q1 | 1.00 CHF | 0.0% |
| 2019 Q2 | 1.00 CHF | 0.0% |
| 2019 Q3 | - CHF | -100.0% |
| 2018 Q1 | - CHF | 100.0% |
| 2018 Q2 | - CHF | 0.0% |
| 2018 Q4 | 1.00 CHF | 0.0% |
| 2018 Q3 | 1.00 CHF | 0.0% |
| 2018 FY | -2.29 Million CHF | 75.7% |
| 2017 FY | -9.43 Million CHF | -943400100.0% |
| 2017 Q4 | -9.43 Million CHF | 0.0% |
| 2017 Q3 | - CHF | 0.0% |
| 2017 Q2 | - CHF | 0.0% |
| 2017 Q1 | - CHF | -100.0% |
| 2016 FY | 1.00 CHF | -100.0% |
| 2016 Q3 | - CHF | -100.0% |
| 2016 Q1 | - CHF | -100.0% |
| 2016 Q4 | 1.00 CHF | 0.0% |
| 2016 Q2 | 1.00 CHF | 0.0% |
| 2015 Q4 | 126.47 Thousand CHF | 0.0% |
| 2015 Q2 | 515.28 Thousand CHF | 0.0% |
| 2015 Q1 | - CHF | -100.0% |
| 2015 FY | 126.47 Thousand CHF | -66.69% |
| 2014 FY | 379.67 Thousand CHF | 0.0% |
| 2014 Q4 | 379.67 Thousand CHF | 0.0% |
| 2014 Q1 | - CHF | 0.0% |
| 2013 FY | - CHF | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Addex Therapeutics Ltd | - CHF | NaN% |
| BB Biotech AG | -2.63 Billion CHF | 100.0% |
| Basilea Pharmaceutica AG | 26.41 Million CHF | 100.0% |
| Evolva Holding SA | - CHF | NaN% |
| Idorsia Ltd | 59.14 Million CHF | 100.0% |
| Kuros Biosciences AG | 4.85 Million CHF | 100.0% |
| Relief Therapeutics Holding AG | 557 Thousand CHF | 100.0% |
| Santhera Pharmaceuticals Holding AG | 1.81 Million CHF | 100.0% |